Hostname: page-component-848d4c4894-4hhp2 Total loading time: 0 Render date: 2024-05-21T15:20:42.028Z Has data issue: false hasContentIssue false

Manic episode secondary to maca

Published online by Cambridge University Press:  23 March 2020

P. Quandt*
Affiliation:
Hospital Universitario de Canarias, Psiquiatría, La Laguna, Spain
M. Puga
Affiliation:
Hospital Universitario Nuestra Señora de Candelaria, Psiquiatría, S/C de Tenerife, Spain
*
* Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Maca (Lepidium meyenii) is a plant grown in the Andes Mountains, formerly used for nutritional purposes. Nowadays is used as a nutritional supplement and energizing.

Objectives

To describe a case of manic episode secondary to maca consumption, as an ingredient of an energizing product.

Aims

To report on antidepressant properties of maca, based on a clinical case.

Methods

X. is a 27-years-old male without any psychiatric history. He came to the emergency service because of the presence of sudden onset behavioral disorders, presenting a manic-like episode of seven hours of evolution. His symptoms consisted in psychomotor restlessness, hyperactivity, insomnia, verbose and loud speech, hyperthymia, megalomaniac verbalizations, and unsuitable future plans. The patient had self-awareness of his symptoms and was self-critical with his behavior. He reported he was consuming an energizing supplement containing maca from about two weeks ago. Treatment with olanzapine 20 mg was initiated, and the patient remained under observation for 24 hours.

Results

Symptomatology subsided completely after 24 hours. The patient is discharged from the hospital with diagnosis of manic episode secondary to maca, without any treatment. He was advice to not take stimulants.

Conclusions

There are studies reporting that maca plant has antidepressant properties, associated with the activation of noradrenergic and dopaminergic systems, as well as the attenuation of oxidative stress. However, more studies are needed to identify specific compounds that produce these effects.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
EV203
Copyright
Copyright © European Psychiatric Association 2016
Submit a response

Comments

No Comments have been published for this article.